$1.1 Billion is the total value of KINGDON CAPITAL MANAGEMENT, L.L.C.'s 54 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SPY | New | SPDR S&P 500 ETF TRput | $164,973,000 | – | 535,000 | +100.0% | 15.01% | – |
| IWM | New | ISHARES TRput | $101,658,000 | – | 710,000 | +100.0% | 9.25% | – |
| QQQ | New | INVESCO QQQ TRput | $99,411,000 | – | 401,500 | +100.0% | 9.04% | – |
| APG | New | API GROUP CORP | $18,752,000 | – | 1,543,344 | +100.0% | 1.71% | – |
| XBI | New | SPDR SER TRput | $16,793,000 | – | 150,000 | +100.0% | 1.53% | – |
| ZM | New | ZOOM VIDEO COMMUNICATIONS INput | $15,212,000 | – | 60,000 | +100.0% | 1.38% | – |
| SPLK | New | SPLUNK INC | $14,445,000 | – | 72,700 | +100.0% | 1.31% | – |
| JD | New | JD.COM INCspon adr cl a | $12,355,000 | – | 205,300 | +100.0% | 1.12% | – |
| LX | New | LEXINFINTECH HLDGS LTDadr | $12,236,000 | – | 1,150,000 | +100.0% | 1.11% | – |
| DHR | New | DANAHER CORPORATION | $8,187,000 | – | 46,300 | +100.0% | 0.74% | – |
| SRI | New | STONERIDGE INC | $8,167,000 | – | 395,301 | +100.0% | 0.74% | – |
| AXON | New | AXON ENTERPRISE INC | $7,850,000 | – | 80,000 | +100.0% | 0.71% | – |
| BHVN | New | BIOHAVEN PHARMACTL HLDG CO Lcall | $7,311,000 | – | 100,000 | +100.0% | 0.66% | – |
| SE | New | SEA LTDput | $6,434,000 | – | 60,000 | +100.0% | 0.58% | – |
| XLC | New | SELECT SECTOR SPDR TRput | $5,404,000 | – | 100,000 | +100.0% | 0.49% | – |
| WNS | New | WNS HLDGS LTDspon adr | $4,948,000 | – | 90,000 | +100.0% | 0.45% | – |
| IOVA | New | IOVANCE BIOTHERAPEUTICS INCput | $4,118,000 | – | 150,000 | +100.0% | 0.38% | – |
| AUPH | New | AURINIA PHARMACEUTICALS INCcall | $3,250,000 | – | 200,000 | +100.0% | 0.30% | – |
| GRAF | New | GRAF INDL CORP | $2,596,000 | – | 186,750 | +100.0% | 0.24% | – |
| AZEK | New | AZEK CO INCcl a | $637,000 | – | 20,000 | +100.0% | 0.06% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| FLEXION THERAPEUTICS INC | 30 | Q2 2021 | 3.1% |
| SPDR S&P 500 ETF TR | 29 | Q3 2023 | 34.8% |
| ISHARES TR | 27 | Q3 2023 | 13.2% |
| HERON THERAPEUTICS INC | 23 | Q3 2019 | 4.2% |
| SOL GEL TECHNOLOGIES | 23 | Q3 2023 | 1.5% |
| META PLATFORMS INC | 22 | Q3 2023 | 5.9% |
| LIBERTY MEDIA CORP | 21 | Q4 2018 | 1.4% |
| NOMAD HLDGS LTD | 19 | Q3 2020 | 2.1% |
| AMAZON COM INC | 18 | Q3 2022 | 7.6% |
| SPDR SER TR | 18 | Q3 2023 | 5.0% |
View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Praxis Precision Medicines, Inc. | January 25, 2023 | 2,855,989 | 6.1% |
| GTY Technology Holdings Inc. | February 10, 2020 | 1,598,212 | 3.1% |
| Jaguar Health, Inc. | February 10, 2020 | 270 | 0.0% |
| Sesen Bio, Inc. | February 10, 2020 | 4,040,835 | 3.9% |
| Eleven Biotherapeutics, Inc. | April 04, 2018 | 2,213,980 | 5.1% |
| AIT Therapeutics, Inc. | April 02, 2018 | 400,859 | 4.8% |
| FATE THERAPEUTICS INCSold out | February 14, 2018 | 0 | 0.0% |
| Great Elm Capital Group, Inc. | February 14, 2018 | 1,267,030 | 5.0% |
| HERON THERAPEUTICS, INC. /DE/ | February 14, 2018 | 2,179,620 | 3.4% |
| Horizon Pharma plcSold out | February 14, 2018 | 0 | 0.0% |
View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-04-15 |
| 13F-HR/A | 2024-03-18 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-06 |
| SC 13G/A | 2024-02-06 |
| SC 13G/A | 2023-11-29 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G | 2023-04-13 |
View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.